ESK981
Showing 1 - 4 of 4
Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)
Not yet recruiting
- Pancreatic Adenocarcinoma
- +6 more
- ESK981
- (no location specified)
Aug 4, 2023
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
- ESK981
-
Detroit, Michigan
- +1 more
Aug 30, 2022
Renal Cell Carcinoma, Metastatic Trial in Ann Arbor (ESK981, Nivolumab)
Active, not recruiting
- Renal Cell Carcinoma, Metastatic
- ESK981
- Nivolumab
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Sep 8, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Ann Arbor,
Recruiting
- Castration Levels of Testosterone
- +4 more
- Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981
- Nivolumab
-
Ann Arbor, Michigan
- +1 more
Oct 4, 2020